Nyxoah Archives | Page 3 of 11 | Be Korea-savvy
Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Mont-Saint-Guibert, Belgium, July 27 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Canaccord Genuity 43rd Growth Conference, which takes place August 7 – 10, 2023 in Boston, Massachusetts. [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), July 27 (Korea Bizwire) – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 4,924,151.05 Total number of securities carrying voting rights: 28,663,985 (all ordinary shares) Total number of [...]

Nyxoah Reports First Quarter 2023 Financial and Operating Results

Nyxoah Reports First Quarter 2023 Financial and Operating Results

Mont-Saint-Guibert, Belgium, May 16 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the first quarter of 2023.   Recent Financial and Operating Highlights  Completed all 115 implants [...]

Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023

Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023

Mont-Saint-Guibert, Belgium, May 12 (Korea Bizwire) — The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders’ meeting of the Company, to be held on Wednesday, June 14, 2023 at 2:00 p.m. CET at the Company’s seat, or at such other place as will be indicated prior to such time. The Company will also set [...]

Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Mont-Saint-Guibert, Belgium, May 10 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Christoph Eigenmann as Chief Commercial Officer. Christoph will oversee commercial activities globally, be responsible for sales and marketing in existing [...]

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

Mont-Saint-Guibert, Belgium, May 1 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter of 2023 on Tuesday, May  16, 2023, after market close. Company management [...]

Publication Relating to Transparency Notifications

Publication Relating to Transparency Notifications

Mont-Saint-Guibert (Belgium), April 20 (Korea Bizwire) – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Together Partnership On April 18, 2023, Nyxoah received a transparency notification from Together Partnership following the crossing of the 10% [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), April 17 (Korea Bizwire) – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.  Share capital: EUR 4,923,807.45  Total number of securities carrying voting rights: 28,661,985 (all ordinary shares)   Total number of voting rights (= denominator): 28,661,985 (all [...]

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

Mont-Saint-Guibert, Belgium, April 13 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $3.0 million in gross proceeds pursuant to the Company’s $50 million at-the-market (“ATM”) program established on [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), March 31 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.  Share capital: EUR 4,859,382.45   Total number of securities carrying voting rights: 28,286,985 (all ordinary shares)   Total number of voting rights (= denominator): 28,286,985 (all [...]